Tenaya Therapeutics, Inc.
TNYA
$0.4912
$0.03066.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 20.37% | 12.04% | 11.54% | -1.55% | 10.68% |
| Total Depreciation and Amortization | -4.22% | -3.67% | -3.28% | 1.17% | 3.02% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -32.40% | 10.25% | 34.98% | 34.61% | 74.29% |
| Change in Net Operating Assets | -54.40% | -7.60% | -383.89% | 17.97% | -113.45% |
| Cash from Operations | 16.13% | 16.08% | 9.93% | 5.38% | 3.34% |
| Capital Expenditure | 48.22% | -2,200.00% | 64.90% | 10.33% | 50.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 198.50% | -198.09% | -14.25% | -145.17% | -314.58% |
| Cash from Investing | 194.53% | -198.72% | -13.83% | -155.69% | -349.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.62% | -- | -86.36% | -- | -99.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.62% | -- | -86.36% | 9,435.53% | -99.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 89.28% | -828.51% | -147.04% | 159.93% | -160.01% |